vs

Side-by-side financial comparison of GLOBUS MEDICAL INC (GMED) and REPUBLIC AIRWAYS HOLDINGS INC. (RJET). Click either name above to swap in a different company.

REPUBLIC AIRWAYS HOLDINGS INC. is the larger business by last-quarter revenue ($1.1B vs $826.4M, roughly 1.3× GLOBUS MEDICAL INC). Over the past eight quarters, GLOBUS MEDICAL INC's revenue compounded faster (16.7% CAGR vs 3.9%).

Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.

Republic Airways Holdings Inc. is an American airline holding company based in Indianapolis, Indiana. The company owns two regional airlines, Mesa Airlines and Republic Airways. Together the two airlines operate the world's largest fleet of Embraer 170 and Embraer 175 aircraft. The majority of the shares of company are owned by the mainline carriers that contract with Republic, American Airlines Group, Delta Air Lines, and United Airlines.

GMED vs RJET — Head-to-Head

Bigger by revenue
RJET
RJET
1.3× larger
RJET
$1.1B
$826.4M
GMED
Faster 2-yr revenue CAGR
GMED
GMED
Annualised
GMED
16.7%
3.9%
RJET

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GMED
GMED
RJET
RJET
Revenue
$826.4M
$1.1B
Net Profit
$140.6M
Gross Margin
68.4%
Operating Margin
20.5%
22.0%
Net Margin
17.0%
Revenue YoY
25.7%
Net Profit YoY
430.4%
EPS (diluted)
$1.01
$3.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GMED
GMED
RJET
RJET
Q4 25
$826.4M
$1.1B
Q3 25
$769.0M
$90.7M
Q2 25
$745.3M
$92.8M
Q1 25
$598.1M
$94.7M
Q4 24
$657.3M
$808.3M
Q3 24
$625.7M
Q2 24
$629.7M
$110.8M
Q1 24
$606.7M
$131.6M
Net Profit
GMED
GMED
RJET
RJET
Q4 25
$140.6M
Q3 25
$119.0M
$-14.1M
Q2 25
$202.8M
$20.9M
Q1 25
$75.5M
$-58.6M
Q4 24
$26.5M
$97.8M
Q3 24
$51.8M
Q2 24
$31.8M
$-19.9M
Q1 24
$-7.1M
$11.7M
Gross Margin
GMED
GMED
RJET
RJET
Q4 25
68.4%
Q3 25
67.2%
Q2 25
66.6%
Q1 25
67.3%
Q4 24
59.9%
Q3 24
56.8%
Q2 24
58.7%
Q1 24
60.2%
Operating Margin
GMED
GMED
RJET
RJET
Q4 25
20.5%
22.0%
Q3 25
17.9%
-10.1%
Q2 25
10.2%
-0.2%
Q1 25
16.2%
-60.4%
Q4 24
9.2%
18.7%
Q3 24
7.7%
Q2 24
7.9%
-8.1%
Q1 24
1.3%
8.8%
Net Margin
GMED
GMED
RJET
RJET
Q4 25
17.0%
Q3 25
15.5%
-15.6%
Q2 25
27.2%
22.5%
Q1 25
12.6%
-61.9%
Q4 24
4.0%
12.1%
Q3 24
8.3%
Q2 24
5.0%
-18.0%
Q1 24
-1.2%
8.9%
EPS (diluted)
GMED
GMED
RJET
RJET
Q4 25
$1.01
$3.13
Q3 25
$0.88
$-0.34
Q2 25
$1.49
$0.50
Q1 25
$0.54
$-1.42
Q4 24
$0.19
$2.42
Q3 24
$0.38
Q2 24
$0.23
$-0.48
Q1 24
$-0.05
$0.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GMED
GMED
RJET
RJET
Cash + ST InvestmentsLiquidity on hand
$557.2M
$296.5M
Total DebtLower is stronger
$882.9M
Stockholders' EquityBook value
$4.6B
$1.3B
Total Assets
$5.3B
$3.3B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GMED
GMED
RJET
RJET
Q4 25
$557.2M
$296.5M
Q3 25
$18.8M
$38.7M
Q2 25
$42.5M
Q1 25
$54.1M
Q4 24
$890.1M
$302.0M
Q3 24
$71.9M
Q2 24
$82.5M
$16.3M
Q1 24
$80.4M
$18.5M
Total Debt
GMED
GMED
RJET
RJET
Q4 25
$882.9M
Q3 25
$27.0M
Q2 25
$28.2M
Q1 25
$31.7M
Q4 24
$752.2M
Q3 24
Q2 24
$287.7M
Q1 24
$299.0M
Stockholders' Equity
GMED
GMED
RJET
RJET
Q4 25
$4.6B
$1.3B
Q3 25
$4.4B
$-52.6M
Q2 25
$4.3B
$-38.7M
Q1 25
$4.1B
$-59.8M
Q4 24
$4.2B
$1.1B
Q3 24
$4.1B
Q2 24
$4.0B
$134.9M
Q1 24
$3.9B
$154.7M
Total Assets
GMED
GMED
RJET
RJET
Q4 25
$5.3B
$3.3B
Q3 25
$5.1B
$158.9M
Q2 25
$5.0B
$178.6M
Q1 25
$4.7B
$215.0M
Q4 24
$5.3B
$2.8B
Q3 24
$5.1B
Q2 24
$5.0B
$664.4M
Q1 24
$4.9B
$706.3M
Debt / Equity
GMED
GMED
RJET
RJET
Q4 25
0.66×
Q3 25
Q2 25
Q1 25
Q4 24
0.68×
Q3 24
Q2 24
2.13×
Q1 24
1.93×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GMED
GMED
RJET
RJET
Operating Cash FlowLast quarter
$248.6M
Free Cash FlowOCF − Capex
$202.4M
FCF MarginFCF / Revenue
24.5%
Capex IntensityCapex / Revenue
5.6%
Cash ConversionOCF / Net Profit
1.77×
TTM Free Cash FlowTrailing 4 quarters
$588.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GMED
GMED
RJET
RJET
Q4 25
$248.6M
Q3 25
$249.7M
Q2 25
$77.9M
$-9.4M
Q1 25
$177.3M
Q4 24
$210.3M
$184.0M
Q3 24
$203.7M
Q2 24
$54.3M
$11.2M
Q1 24
$52.4M
Free Cash Flow
GMED
GMED
RJET
RJET
Q4 25
$202.4M
Q3 25
$213.9M
Q2 25
$31.3M
$-10.5M
Q1 25
$141.2M
Q4 24
$193.2M
$-42.7M
Q3 24
$161.7M
Q2 24
$26.5M
$7.5M
Q1 24
$23.8M
FCF Margin
GMED
GMED
RJET
RJET
Q4 25
24.5%
Q3 25
27.8%
Q2 25
4.2%
-11.3%
Q1 25
23.6%
Q4 24
29.4%
-5.3%
Q3 24
25.8%
Q2 24
4.2%
6.8%
Q1 24
3.9%
Capex Intensity
GMED
GMED
RJET
RJET
Q4 25
5.6%
Q3 25
4.7%
Q2 25
6.2%
1.2%
Q1 25
6.0%
Q4 24
2.6%
28.0%
Q3 24
6.7%
Q2 24
4.4%
3.4%
Q1 24
4.7%
Cash Conversion
GMED
GMED
RJET
RJET
Q4 25
1.77×
Q3 25
2.10×
Q2 25
0.38×
-0.45×
Q1 25
2.35×
Q4 24
7.94×
1.88×
Q3 24
3.93×
Q2 24
1.71×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GMED
GMED

Other$391.8M47%
Nevro Merger Agreement$293.6M36%
Enabling Technologies$141.0M17%

RJET
RJET

United Airlines$517.5M48%
Delta Air Lines$409.7M38%
Other$49.9M5%
Republic Airways Holdings Inc.$42.2M4%
Other Airlines$25.7M2%
LIFT Academy$23.2M2%

Related Comparisons